Pharmaceutical Commerce: April 2025 Interactive Digital Edition
View the Pharmaceutical Commerce April 2025 issue in an interactive format.
The Cold Chain's Evolution
The April issue of Pharmaceutical Commerce examines the accelerated activity—and many ever-expanding layers—of temperature-sensitive transport in pharma.
Tariffs Galore: Where Do We Stand?
One expert's take on reshoring pharma manufacturing services in the US amid likely tariffs to drugs looming.
Conference Connect: Progressing Patient Assistance
Access USA converges in Philadelphia to explore new—and needed—solutions to boost patient outcomes.
The Hot Market for Cold Chain Services
Vendors are growing, and product and service offerings are expanding.
Reducing Risk in the Pharmaceutical Cold Chain
When delays and disruptions threaten not only product integrity but patient well-being, thorough risk assessment and mitigation are essential.
An AI-Pharma Transport Collaboration
How artificial intelligence tools are helping to optimize the pharmaceutical transport process.
The Role of CDMOs in the Pharma Cold Chain Machine
Exploring the importance of contract development and manufacturing organizations in advancing the latest technology for effective delivery of temperature-sensitive medicines.
From Prescription to Patient: Four Ways to Increase Speed to Therapy
The key strategies for reducing or eliminating post-prescription abandonment.
What Your Data Can Tell You About Illicit Trade Risk
Why taking proactive steps—and combing the right data sources—is critical to informed decision-making in risk management.
Healthcare Scorecard from Patients with Chronic Illness
A look at the prevailing factors impacting treatment access in 2025.
Popping the Gross-to-Net Bubble, Part III: The Pharmacy Benefit
How pharma manufacturers can steadily navigate GTN components and complexities when planning pharmacy benefit reimbursement.
US Drug Price Negotiations and Transparency
Respective industry and government agendas could significantly reshape the US prescription drug market.
Strategies to Modernize, Future-Proof, and Secure the Healthcare Supply Chain
Ensuring that essential treatments reach patients safely and efficiently is an increasing imperative in today's pharma landscape.
Maintaining R&D Investments in the IRA Era
How data-driven insights can help pharma companies balance their revenue management and innovation strategies—including resource allocation, pricing, and market access.
Beyond the Hype: GenAI’s Real Impact on Life Sciences Manufacturing
Taking stock of today's gains and tomorrow's potential for generative artificial intelligence in reshaping the industry.
